share_log

Lake Street Maintains Buy on Better Therapeutics, Lowers Price Target to $3

Benzinga ·  Aug 10, 2023 16:04

Lake Street analyst Thomas Flaten maintains Better Therapeutics (NASDAQ:BTTX) with a Buy and lowers the price target from $5 to $3.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment